Actinium Pharmaceuticals Revenue and Competitors

Claim your profile

Sydney, AUS

Location

$106.1M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Actinium Pharmaceuticals's total funding is $106.1M.

Employee Data

  • Actinium Pharmaceuticals has 56 Employees.(i)
  • Actinium Pharmaceuticals grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$231M149047%N/AN/A
#2
$7.4M48-33%N/AN/A
#3
N/A560%$106.1MN/A
#4
$7.6M49N/AN/AN/A

Actinium Pharmaceuticals, Inc. is engaged in the development and commercialization of alpha particle immunotherapeutics based on its unique patent position for the utilization of actinium-225 and bismuth-213. It has facilities in Florham Park, New Jersey and Oak Ridge, Tennessee.

keywords:N/A

$106.1M

Total Funding

56

Number of Employees

N/A

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Actinium Pharmaceuticals News

2022-04-20 - Actinium Pharmaceuticals, Inc. to Highlight Iomab-B Pivotal ...

Actinium Pharmaceuticals, Inc. to Highlight Iomab-B Pivotal Phase 3 SIERRA Trial Data at the Transplantation & Cellular Therapy Tandem Meetings...

2022-04-13 - Actinium Pharmaceuticals Highlights Potent Anti-Tumor ...

Data Supports Actinium Pharmaceutical's research collaboration with AVEO Oncology to develop and advance a HER3 targeted radiotherapy to...

2022-04-13 - Actinium Pharmaceuticals, Inc. and Immedica Announce ...

Actinium Pharmaceuticals, Inc. and Immedica Announce Commercialization Agreement for Iomab-B (131I apamistamab) in Europe, the Middle East and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.1M5633%N/A
#2
$12.8M560%N/A
#3
$11.8M56N/AN/A
#4
$10.6M568%N/A
#5
$12.8M56-15%N/A